Navigation Links
Bayer HealthCare and Health Alliance Medical Plans Enter Outcomes-based Agreement
Date:12/6/2011

WAYNE, N.J. and URBANA, Ill., Dec. 6, 2011 /PRNewswire/ -- Bayer HealthCare and Health Alliance Medical Plans have entered into an outcomes-based contract for people with relapsing-remitting multiple sclerosis (MS) who are taking Betaseron® (interferon beta-1b) to reduce the frequency of clinical exacerbations.  The agreement is the first of this type for Bayer HealthCare in the U.S. and is defined by relapses requiring hospitalizations for Betaseron patients covered by Health Alliance. 

"Bayer continually identifies and implements innovative means of supporting our patients," said Alex Santini, Vice President, Managed Markets, Bayer HealthCare.  "This agreement reinforces our commitment to people taking Betaseron and demonstrates our belief that when patients are adherent to their treatment plan, there may be a greater chance for positive outcomes by reducing clinical exacerbations."

Both companies are committed to providing support to people taking Betaseron.  Bayer's patient support program, BETAPLUS®, is designed to help patients get started successfully on Betaseron and remain on their treatment plan.  It provides round-the-clock nurse assistance and access specialists who answer insurance-related questions, among other services.  Health Alliance emphasizes wellness, education and prevention and has assembled networks of the best healthcare professionals.  The National Committee for Quality Assurance (NCQA) has awarded Health Alliance its highest accreditation for its HMO, POS and Medicare HMO products since 1997.

"Today's healthcare environment calls for new ways to improve patient outcomes and reduce costs associated with disease management," said Robert Parker, MD, Chief Medical Officer at Health Alliance.  "This agreement represents the best efforts of Bayer and Health Alliance to address the needs of patients while taking into account economic realities."

INDICATION
'/>"/>

SOURCE Bayer HealthCare
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
2. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
3. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
4. Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 WFH World Congress
5. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
6. Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
7. FDA Approves Bayer HealthCares Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A
8. Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology
9. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
10. Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting
11. Bayer Announces New Data on Novel Anti-cancer Compound BAY 73-4506
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 /PRNewswire-iReach/ -- Market ... Scanner Industry, 2009-2019 is a professional and in-depth ... Crystallography Scanner industry . The report firstly reviews ... its classification, application and manufacturing technology. The report ... X-Ray Crystallography Scanner listing their product specification, capacity, ...
(Date:8/29/2014)... WILSONVILLE, Ore. , Aug. 29, 2014 /PRNewswire-iReach/ ... its Accessory (Axilla) Strap for the SAM Junctional ... SAM Medical Products announced ... a voluntary recall to address a potential issue ... strap used for the Axilla application of the ...
(Date:8/29/2014)... 2014 Medina Medical announced today that Mr. ... the Board of Directors on August 18, 2014. Mr. ... commercialization experience, including over a decade of direct experience ... a Partner of the medical device incubator The Foundry, ... Foundry start-ups. Mr. Engelson previously served as the Chief ...
Breaking Medicine Technology:X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 2X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 3X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 5SAM Medical Products Implements Voluntary Recall of its Accessory (Axilla) Strap for the SAM Junctional Tourniquet. 2Medina Medical Announces Erik T. Engelson Joins as Chief Executive Officer 2
... in Patients with,Chronic Decompensated Heart Failure Presented at ... --, MOUNTAIN VIEW, Calif. and NEW ORLEANS, March ... an exploratory,920-patient, Phase 2 study of nesiritide (NATRECOR(R)) ... composite of death and,cardiorenal hospitalization at 12 weeks, ...
... NEW ORLEANS, March 26, 2007 /PRNewswire/ -- ... for the CYPHER(R) Sirolimus-eluting,Coronary Stent reported favorable ... to clinical investigators at the of,Cardiology's 56th ... Registry is a prospective, single-arm study designed,to ...
Cached Medicine Technology:Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 2Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 3Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 4Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 5Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 6Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 7Two-Year Patient Registry Results Support Safety and Efficacy of,Cypher Sirolimus-Eluting Coronary Stent in 'Real World' Uses 2Two-Year Patient Registry Results Support Safety and Efficacy of,Cypher Sirolimus-Eluting Coronary Stent in 'Real World' Uses 3Two-Year Patient Registry Results Support Safety and Efficacy of,Cypher Sirolimus-Eluting Coronary Stent in 'Real World' Uses 4
(Date:9/1/2014)... (PRWEB) September 01, 2014 The National ... to announce that Dawn Bazarko, DNP, MPH, RN, and ... of the American Academy of Nursing. They will be ... RN-BC, CCM, FACHE, whose induction we reported last May. ... 18, 2014, during the 2014 American Academy of Nursing ...
(Date:9/1/2014)... involved in federally-filed Tylenol lawsuits ( http://www.tylenollawsuitclaims.com/ ) are ... where issues related to claims involving the pain reliever ... Bernstein Liebhard LLP reports. , According to a ... the meeting is scheduled to take place on September ... of several Tylenol conferences that have taken place this ...
(Date:9/1/2014)... (PRWEB) August 31, 2014 Daily Gossip ... online resource and community that gives members access to ... resources. , This online resource aims to help both ... well as artists who are looking for inspiration in ... more about Tattoo Me Now by visiting the official ...
(Date:9/1/2014)... Developers of FCPX 3rd Party Products have ... ProWorld Plugin from Pixel Film Studios. , “ProWorld has pushed ... and users now have the ability to create a 3D ... of Pixel Film Studios. “Blurring the line between professional and ... to turn a 2D HDRI image or Skybox Texture into ...
(Date:8/31/2014)... An analysis of 32 studies compiled by University ... between lower levels of Vitamin D and a higher ... 2014 issue of American Journal of Public Health, ... D found in blood. , Researchers found that ... 9 nanograms/milliliter (ng/mL) were twice as likely to die ...
Breaking Medicine News(10 mins):Health News:Two Additional NAHN Members to be Inducted as Fellows of the American Academy of Nursing 2Health News:Two Additional NAHN Members to be Inducted as Fellows of the American Academy of Nursing 3Health News:Two Additional NAHN Members to be Inducted as Fellows of the American Academy of Nursing 4Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 2Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 3Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 4Health News:Tattoo Me Now Review Reveals Unique Ideas for Tattoo Designs 2Health News:Pixel Film Studios Released a New Tutorial Entitled ProWorld Lesson Exclusively for Final Cut Pro X 2Health News:NutriGold Highlights New Study on the Importance of Vitamin D to Our Life Span 2Health News:NutriGold Highlights New Study on the Importance of Vitamin D to Our Life Span 3Health News:NutriGold Highlights New Study on the Importance of Vitamin D to Our Life Span 4
... , ... maker Vinomis Laboratories, makers of the red wine and Resveratrol-based anti-aging supplement Vindure 900, ... be used to expand the company’s marketing, advertising, and free trial programs. ... (PRWEB) May ...
... ... Q1 , ... N.J. (PRWEB) May 3, 2010 -- iCIMS, the second largest Software-as-a-Service (SaaS) provider of ... influx of new healthcare clients turning to the iCIMS Talent Platform . Notable ...
... ... website on the subject of hives today when she unveiled Hives.org. Dr. Young has ... 30,000 a month via Hives.org. Learn more at http://www.hives.org . , ... (PRWEB) February 25, 2010 -- ...
... ... Pain and Disability in U.S. , ... Belleville, Ill. (Vocus) May 3, 2010 -- The National Fibromyalgia ... and understanding during Fibromyalgia Awareness Day on May 12. Allsup , a ...
... ... Jim Greer, an experienced leader in energy management, LEED ... as Director of Energy Efficiency and Sustainability for the 20 year ... for clients in the areas of Electricity, Natural Gas, Water/Sewer, Waste ...
... Executive ... Fan Page. The Social Back Doctors Revolution will be spreading into YouTube, Twitter, the Blogosphere ... ... as they pave the way for the medical field in the social media space. Dr. ...
Cached Medicine News:Health News:Vinomis Laboratories Completes Additional Funding Round 2Health News:Growing Number of Healthcare Organizations Choose the Talent Platform 2Health News:Growing Number of Healthcare Organizations Choose the Talent Platform 3Health News:Growing Number of Healthcare Organizations Choose the Talent Platform 4Health News:Hives Treatment Specialist Dr. Tiffany Young Vows to Cure 30,000 Cases of Hives a Month with Hives Rash Website: Hives.org 2Health News:Make Fibromyalgia Visible May 12 2Health News:Make Fibromyalgia Visible May 12 3Health News:Jim Greer joins Revenue Source Group Inc. 2Health News:San Francisco Chiropractor Goes Social: Join the Social Back Doctor Revolution on Facebook Now -- Win Prizes, Cash, and Services 2
... for users of "completely-in-the-canal" (CIC) instruments ... - must send eartip., ,Impressions ... ,Westone custom products for the ... network of hearing healthcare providers. These ...
Advanced architecture. Small, lightweight and compact. Easy to use....
... fibre bronchoscopy: The HF-compatible V series from ... fibre bronchoscopes are measured., ,The HF-compatible ... the FB-19TV, FB-18V and FB-15V models along ... pediatric FB-8V, offer much better image quality ...
... bronchoscopy: The HF-compatible V series from Pentax, ... bronchoscopes are measured., ,The HF-compatible series ... FB-19TV, FB-18V and FB-15V models along with ... FB-8V, offer much better image quality thanks ...
Medicine Products: